Innophore, a Graz-based bioinformatics company, has partnered with NVIDIA to develop artificial intelligence for the early detection of drug side effects. Together, they created a comprehensive dataset of human protein
Innophore was selected among the top five Material Informatics startups worldwide by StartUs Insights, based on an analysis of 173 companies working on data-driven simulation and discovery. The ranking highlights
This in-depth feature by Drug Discovery & Development traces Innophore’s journey from a 30-person Austrian startup to a strategic NVIDIA partner showcased at both the J.P. Morgan Healthcare Conference and
Austrian technology outlet futurezone reports on the expanding partnership between NVIDIA and the Graz-based biotech company Innophore, highlighted by NVIDIA CEO Jensen Huang at CES in Las Vegas. The collaboration
Pharmaceutical Technology reports on NVIDIA’s endorsement of the Innophore partnership for modelling drug dynamics with AI. Innophore’s CavitOmiX platform uses deep learning to screen for new drug candidates, predict hidden
In this official NVIDIA Success Story, Innophore demonstrates how GPU-accelerated computing, the BioNeMo framework, and Amazon Web Services are revolutionizing drug discovery workflows. By leveraging NVIDIA GPUs and RAPIDS, Innophore
What began as a practical exercise in a structural bioinformatics course at the University of Graz led to a Nature Correspondence: we identified systematic stereochemical errors in AlphaFold 3, the
Yahoo Finance, via GlobalData, reports on NVIDIA championing the Innophore partnership to model drug dynamics with artificial intelligence. The CavitOmiX AI platform is designed to predict hidden side effects and
Austrian startup media Trending Topics reports on the collaboration between Innophore and NVIDIA, announced during Jensen Huang’s CES keynote address in January 2025. The Graz-based company, founded in 2017, uses
Austrian public broadcaster ORF Steiermark reports on how Innophore and NVIDIA have developed AI technology for the early detection of drug side effects. The collaboration produced a dataset containing 3D
Published in Nature Scientific Data, this paper presents a comprehensive dataset of predicted protein structures for 42,042 distinct human proteins, generated using NVIDIA’s BioNeMo platform combined with Innophore’s CavitomiX technology.
At the 42nd J.P. Morgan Healthcare Conference in San Francisco, NVIDIA CEO Jensen Huang highlighted the Innophore partnership as a key example of how generative AI is transforming drug discovery
Published in Nature Scientific Reports, this study demonstrates the power of Innophore’s DrugSolver CavitomiX pipeline for computational drug repurposing. By analyzing cavity-based point clouds representing the physico-chemical properties of SARS-CoV-2
Germany’s leading broadsheet newspaper Frankfurter Allgemeine Zeitung featured Innophore’s work on computational structural virology and the application of the Catalophore technology to SARS-CoV-2 variant analysis. The article highlights how a
January 2020 to March 2021 190 press clippings are listed below. # Publication Media Titel (GE) Title (EN) 190 March 2021 Kleine Zeitung online Schneller als das Virus